Vitamin D and Sjögren syndrome

Autoimmunity Reviews

Volumn 16, Issue 6, 2017, Pages 587-593

  Garcia Carrasco, Mario ^a,b   Jiménez Herrera, Erick Alejandro ^a   Gálvez Romero, Jose Luis ^c   de Lara, Luis Vázquez ^b   Mendoza Pinto, Claudia ^a,b   Etchegaray Morales, Ivet ^a   Munguía Realpozo, Pamela ^a   Ruíz Argüelles, Alejandro ^d,e   Jose, Rosas ^f   Vera Recabarren, Mauricio ^g   Cervera, Ricard ^h  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^d Laboratorios Clinicos de Puebla   (Mexico)

^e UNIVERSIDAD DE LAS AMÉRICAS PUEBLA   (Mexico)

^f Marina Baixa Hospital   (Spain)

^g Hospital Exequiel González Cortés   (Chile)

^h HOSPITAL CLÍNIC   (Spain)

Author keywords

Environment; Immunomodulation; Sj gren syndrome; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; ANTINUCLEAR ANTIBODY; RHEUMATOID FACTOR; VITAMIN D; VITAMIN D RECEPTOR; VITAMIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; IMMUNE SYSTEM; IMMUNOBIOLOGY; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOMA; METABOLITE; NEUROPATHY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; REVIEW; SJOEGREN SYNDROME; ULTRAVIOLET RADIATION; VIRUS INFECTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOIMMUNITY; HUMANS; SJOGREN'S SYNDROME; VITAMIN D; VITAMINS;

EID: 85017507633     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.04.004     Document Type: Review

References (59)

1. Cutolo, M., Pizzorni, C., Sulli, A., Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev 11 (2011), 84–87.
2. Mazzaferro, S., Pasquali, M., Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be?. Nephrol Dial Transplant 31 (2016), 23–30.
3. Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., Carmeliet, G., Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96 (2016), 365–408.
4. Kiraly, S.J., Kiraly, M.A., Hawe, R.D., Makhani, N., Vitamin D as a neuroactive substance: review. ScientificWorldJournal 6 (2006), 125–139.
5. Veldurthy, V., Wei, R., Oz, L., Dhawan, P., Jeon, Y.H., Christakos, S., Vitamin D, calcium homeostasis and aging. Bone Res, 4, 2016, 16041.
6. Bhalla, A.K., Amento, E.P., Clemens, T.L., Holick, M.F., Krane, S.M., Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57 (1983), 1308–1310.
7. Carlberg, C., The vitamin D(3) receptor in the context of the nuclear receptor superfamily: the central role of the retinoid X receptor. Endocrine 4 (1996), 91–105.
8. Carlberg, C., Haq, A., The concept of the personal vitamin D response index. J Steroid Biochem Mol Biol, 26, 2016.
9. Wei, R., Christakos, S., Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients 7 (2015), 8251–8260.
10. Peelen, E., Knippenberg, S., Muris, A.H., Thewissen, M., Smolders, J., Tervaert, J.W., et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 10 (2011), 733–743.
11. Liu, P.T., Schenk, M., Walker, V.P., Dempsey, P.W., Kanchanapoomi, M., Wheelwright, M., et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One, 4, 2009, e5810.
12. Mora, J.R., Iwata, M., von Andrian, U.H., Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8 (2008), 685–698.
13. Joshi, S., Pantalena, L.C., Liu, X.K., Gaffen, S.L., Liu, H., Rohowsky-Kochan, C., et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 31 (2011), 3653–3669.
14. Ferreira, G.B., Vanherwegen, A.S., Eelen, G., Gutierrez, A.C., Van, L.L., Marchal, K., et al. Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep, 2015, 10.1016/j.celrep.2015.01.013 [Epub ahead of print].
15. Patel, D.D., Kuchroo, V.K., Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 43 (2015), 1040–1051.
16. Bruce, D., Yu, S., Ooi, J.H., Cantorna, M.T., Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 23 (2011), 519–528.
17. Wen, H., Luo, J., Zhang, X., Zhang, C., Zhao, X., Wang, X., et al. 1,25(OH)2-vitamin-D3 attenuates Th17-related cytokines expression in peripheral blood mononuclear cells in patients with early-diagnosed rheumatoid arthritis. Zhonghua Nei Ke Za Zhi 54 (2015), 317–321.
18. Ramagopalan, S.V., Goldacre, R., Disanto, G., Giovannoni, G., Goldacre, M.J., Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies. BMC Med, 11, 2013, 171.
19. Clifford, J., Rosen, M.D., Vitamin D insufficiency. N Engl J Med 364 (2011), 248–254.
20. Garcia-Carrasco, M., Romero, J.L., Vitamin D and autoimmune rheumatic disease. Rheumatol Clin 11 (2015), 333–334.
21. Agmon-Levin, N., Kivity, S., Tzioufas, A.G., Lopez, H.M., Rozman, B., Efes, I., et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. J Autoimmun 39 (2012), 234–239.
22. Spach, K.M., Nashold, F.E., Dittel, B.N., Hayes, C.E., IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177 (2006), 6030–6037.
23. Hayes, C.E., Hubler, S.L., Moore, J.R., Barta, L.E., Praska, C.E., Nashold, F.E., Vitamin D actions on CD4(+) T cells in autoimmune disease. Front Immunol, 6, 2015, 100.
24. Prinz, J.C., Disease mimicry–a pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry?. Autoimmun Rev 3 (2004), 10–15.
25. Gatto, M., Zen, M., Ghirardello, A., Bettio, S., Bassi, N., Iaccarino, L., et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 12 (2013), 523–536.
26. Wahono, C.S., Rusmini, H., Soelistyoningsih, D., Hakim, R., Handono, K., Endharti, A.T., et al. Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. Int J Clin Exp Med 7 (2014), 22–31.
27. Tizaoui, K., Hamzaoui, K., Association between VDR polymorphisms and rheumatoid arthritis disease: systematic review and updated meta-analysis of case-control studies. Immunobiology 220 (2015), 807–816.
28. Yang, C.Y., Leung, P.S., Adamopoulos, I.E., Gershwin, M.E., The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 45 (2013), 217–226.
29. van Etten, E., Verlinden, L., Giulietti, A., Ramos-Lopez, E., Branisteanu, D.D., Ferreira, G.B., et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 37 (2007), 395–405.
30. Monticielo, O.A., Brenol, J.C., Chies, J.A., Longo, M.G., Rucatti, G.G., Scalco, R., et al. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21 (2012), 43–52.
31. Albrecht, J., Atzeni, F., Baldini, C., Bombardieri, S., Dalakas, M.C., Demirkesen, C., et al. Skin involvement and outcome measures in systemic autoimmune diseases. Clin Exp Rheumatol 24 (2006), S52–S59.
32. Baldini, C., Delle, S.A., Luciano, N., Pepe, P., Ferro, F., Talarico, R., et al. Vitamin D in “early” primary Sjogren's syndrome: does it play a role in influencing disease phenotypes?. Rheumatol Int 34 (2014), 1159–1164.
33. Szodoray, P., Horvath, I.F., Papp, G., Barath, S., Gyimesi, E., Csathy, L., et al. The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 49 (2010), 211–217.
34. Tincani, A., Andreoli, L., Cavazzana, I., Doria, A., Favero, M., Fenini, M.G., et al. Novel aspects of Sjogren's syndrome in 2012. BMC Med, 11, 2013, 93.
35. Brito-Zerón, P., Baldini, C., Bootsma, H., Bowman, S., Jonsson, R., Mariette, X., et al. Sjögren syndrome. Nat Rev Dis Prim, 2, 2016, 16047.
36. Kulling, P.M., Olson, K.C., Olson, T.L., Feith, D.J., Loughran, T.P. Jr., Vitamin D in hematological disorders and malignancies. Eur J Haematol, 2016, 15.
37. Rischmueller, M., Tieu, J., Lester, S., Primary Sjogren's syndrome. Best Pract Res Clin Rheumatol 30 (2016), 189–220.
38. Ambrosi, A., Salomonsson, S., Eliasson, H., Zeffer, E., Skog, A., Dzikaite, V., et al. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis 71 (2012), 334–340.
39. Igoe, A., Scofield, R.H., Autoimmunity and infection in Sjogren's syndrome. Curr Opin Rheumatol 25 (2013), 480–487.
40. Pender, M.P., CD8 + T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis, 2012, 2012, 189096.
41. Jabs, D.A., Arnett, F.C., Bias, W.B., Beale, M.G., Familial abnormalities of lymphocyte function in a large Sjogren's syndrome kindred. J Rheumatol 13 (1986), 320–326.
42. Comans-Bitter, W.M., de Groot, R., van den Beemd, R., Neijens, H.J., Hop, W.C., Groeneveld, K., et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 130 (1997), 388–393.
43. Amadori, A., Zamarchi, R., De, S.G., Forza, G., Cavatton, G., Danieli, G.A., et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1 (1995), 1279–1283.
44. Mavragani, C.P., Moutsopoulos, H.M., Sjogren syndrome. CMAJ 186 (2014), E579–E586.
45. Draborg, A., Izarzugaza, J.M., Houen, G., How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?. Curr Opin Rheumatol 28 (2016), 398–404.
46. Hersey, P., Haran, G., Hasic, E., Edwards, A., Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects after exposure to sunlight. J Immunol 131 (1983), 171–174.
47. Cakmak, F.N., Erol, M., Ergul, P., Yalcyner, A., T lymphocytes and vitamins. J Pediatr, 135, 1999, 531.
48. Chen, J., Bruce, D., Cantorna, M.T., Vitamin D receptor expression controls proliferation of naive CD8 + T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol, 15, 2014, 6.
49. Kelly, D.A., Young, A.R., McGregor, J.M., Seed, P.T., Potten, C.S., Walker, S.L., Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 191 (2000), 561–566.
50. Norval, M., The effect of ultraviolet radiation on human viral infections. Photochem Photobiol 82 (2006), 1495–1504.
51. Ponsonby, A.L., McMichael, A., van der Mei, I., Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181-182 (2002), 71–78.
52. Hart, P.H., Gorman, S., Finlay-Jones, J.J., Modulation of the immune system by UV radiation: more than just the effects of vitamin D?. Nat Rev Immunol 11 (2011), 584–596.
53. Biggs, L., Yu, C., Fedoric, B., Lopez, A.F., Galli, S.J., Grimbaldeston, M.A., Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice. J Exp Med 207 (2010), 455–463.
54. Ambrosi, A., Wahren-Herlenius, M., Update on the immunobiology of Sjogren's syndrome. Curr Opin Rheumatol 27 (2015), 468–475.
55. McHugh, J., Connective tissue diseases: new cellular players in Sjogren syndrome pathogenesis. Nat Rev Rheumatol, 12, 2016, 694.
56. Muller, K., Oxholm, P., Sorensen, O.H., Thymann, M., Hoier-Madsen, M., Bendtzen, K., Abnormal vitamin D3 metabolism in patients with primary Sjogren's syndrome. Ann Rheum Dis 49 (1990), 682–684.
57. Zilahi, E., Chen, J.Q., Papp, G., Szanto, A., Zeher, M., Lack of association of vitamin D receptor gene polymorphisms/haplotypes in Sjogren's syndrome. Clin Rheumatol 34 (2015), 247–253.
58. D'Ambrosio, D., Cippitelli, M., Cocciolo, M.G., Mazzeo, D., Di, L.P., Lang, R., et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101 (1998), 252–262.
59. Gatenby, P., Lucas, R., Swaminathan, A., Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol 25 (2013), 184–191.